Companies / Niagen Bioscience, Inc.

Niagen Bioscience, Inc.

Nasdaq: NAGECIK 1386570LOS ANGELES, CA

Financials · FY2025

Revenue$129.42M
Net income$17.38M
Total debt$0
Cash$64.10M
Diluted EPS$0.20
Shares outstanding79.1M

Ownership

79.1M shares outstanding · as of Jul 30, 2026
1.3%Insiders
Ownership
Insiders1.34%1,058,981
10%+ / strategic4.15%3,286,498
Institutions39.93%31,591,490
Public float54.58%43,189,033

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Fried Robert NCEOChief Executive Officer · Director
1.34%1,058,981
Cohen AnnDirector
——
Jaksch Frank L JrDirector
——
Lopez Carlos LuisSVP, General Counsel
——
Ng Wang Yu GaryDirector
——
Pamir OzanChief Financial Officer
——
Patrick KristinDirector
——
Rubin Steven DDirector
——
Shahbazi HamedDirector
——
YU Wing Tak WendyDirector
——

Institutional holders 173

View all →
HolderValue% of shares
Vanguard Group Inc$20.90M4.15%
BlackRock, Inc.$13.35M5.29%
Arrowstreet Capital, Limited Partnership$10.49M3.01%
UBS Group AG$8.98M1.78%
Qube Research & Technologies Ltd$6.75M1.34%
The Goldman Sachs Group, Inc.$6.07M1.21%
Geode Capital Management, LLC$5.93M1.70%
Renaissance Technologies LLC$5.86M1.68%
Dimensional Fund Advisors LP$5.85M1.16%
Morgan Stanley$5.60M1.11%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 24, 2026Fried Robert N
CEO
ExerciseCommon Stock$52.2K+20K
+1.93%
1,058,981
1.34% of shares
low
Jun 24, 2026Shahbazi Hamed
Director
GrantStock Option (right to buy)—+32K
31,746
0.04% of shares
low
Jun 24, 2026Cohen Ann
Director
GrantStock Option (right to buy)—+32K
31,746
0.04% of shares
low
Jun 24, 2026Ng Wang Yu Gary
Director
GrantStock Option (right to buy)—+32K
31,746
0.04% of shares
low
Jun 24, 2026Patrick Kristin
Director
GrantStock Option (right to buy)—+32K
31,746
0.04% of shares
low
Jun 24, 2026YU Wing Tak Wendy
Director
GrantStock Option (right to buy)—+32K
31,746
0.04% of shares
low
Jun 24, 2026Jaksch Frank L Jr
Director
GrantStock Option (right to buy)—+32K
31,746
0.04% of shares
low
Apr 24, 2026Fried Robert N
CEO
ExerciseStock Options (right to buy)—-20K
-100.00%
0
0.00% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—3,286,498—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NAGECommon StockEquity171077407BBG000BG1J71